Expert Review of Hematology, Volume 10, Issue 9 (2017)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Review of Hematology, Volume 10, Issue 9 (2017)

See all volumes and issues
Vol 17, 2024 Vol 16, 2023 Vol 15, 2022 Vol 14, 2021 Vol 13, 2020 Vol 12, 2019 Vol 11, 2018 Volume 10, 2017 Vol 9, 2016 Vol 8, 2015 Vol 7, 2014 Vol 6, 2013 Vol 5, 2012 Vol 4, 2011 Vol 3, 2010 Vol 2, 2009 Vol 1, 2008
Download citations Download PDFs Download issue

Editorial

Editorial
Emerging applications of gene edited T cells for the treatment of leukemia
Christos Georgiadis & Waseem Qasim
Pages: 753-755
Published online: 25 Jul 2017
First Page PreviewforEmerging applications of gene edited T cells for the treatment of leukemia | Full Text | References | PDF (315.3 KB)
  • 2342 Views
  • 11 CrossRef citations
  • 0Altmetric
Free Access

Drug Profile

Article
Mogamulizumab for the treatment of relapsed or refractory adult T-cell leukemia-lymphoma
Frank T. Winsett, Daniel J. Lewis & Madeleine Duvic
Pages: 757-760
Published online: 21 Aug 2017
AbstractforMogamulizumab for the treatment of relapsed or refractory adult T-cell leukemia-lymphoma | Full Text | References | PDF (582.9 KB)
  • 272 Views
  • 5 CrossRef citations
  • 0Altmetric

Perspective

Article
Is now the time for molecular driven therapy for diffuse large B-cell lymphoma?
Alice Di Rocco, Federico De Angelis, Michela Ansuinelli, Robin Foà & Maurizio Martelli
Pages: 761-774
Published online: 25 Jul 2017
AbstractforIs now the time for molecular driven therapy for diffuse large B-cell lymphoma? | Full Text | References | PDF (1.6 MB)
  • 613 Views
  • 11 CrossRef citations
  • 0Altmetric

Review

Review
The evolving role of targeted drugs in the treatment of Hodgkin lymphoma
Dennis A. Eichenauer & Andreas Engert
Pages: 775-782
Published online: 10 Jul 2017
AbstractforThe evolving role of targeted drugs in the treatment of Hodgkin lymphoma | Full Text | References | PDF (646.6 KB)
  • 383 Views
  • 5 CrossRef citations
  • 0Altmetric
Review
Emerging role of immunotherapy in precursor B-cell acute lymphoblastic leukemia
Gautam Kishore Valecha, Uroosa Ibrahim, Sassine Ghanem, Divya Asti, Jean-Paul Atallah & Terenig Terjanian
Pages: 783-799
Published online: 10 Jul 2017
AbstractforEmerging role of immunotherapy in precursor B-cell acute lymphoblastic leukemia | Full Text | References | PDF (1.3 MB)
  • 599 Views
  • 6 CrossRef citations
  • 0Altmetric
Review
Insights into the diagnosis and management of iron deficiency in inflammatory bowel disease
Rayan Bou-Fakhredin, Racha Halawi, Joseph Roumi & Ali Taher
Pages: 801-808
Published online: 26 Jul 2017
AbstractforInsights into the diagnosis and management of iron deficiency in inflammatory bowel disease | Full Text | References | PDF (716.3 KB)
  • 457 Views
  • 13 CrossRef citations
  • 0Altmetric
Review
Insights into the management of chronic myeloid leukemia in resource-poor settings: a Mexican perspective
Andrés Gomez-de-León, David Gómez-Almaguer, Guillermo J. Ruiz-Delgado & Guillermo J. Ruiz-Arguelles
Pages: 809-819
Published online: 03 Aug 2017
AbstractforInsights into the management of chronic myeloid leukemia in resource-poor settings: a Mexican perspective | Full Text | References | PDF (1.2 MB)
  • 145 Views
  • 4 CrossRef citations
  • 0Altmetric
Review
The potential role of endothelial dysfunction and platelet activation in the development of thrombotic risk in COPD patients
Mario Malerba, Matteo Nardin, Alessandro Radaeli, Paolo Montuschi, Giovanna E Carpagnano & Enrico Clini
Pages: 821-832
Published online: 12 Jul 2017
AbstractforThe potential role of endothelial dysfunction and platelet activation in the development of thrombotic risk in COPD patients | Full Text | References | PDF (1.2 MB)
  • 556 Views
  • 19 CrossRef citations
  • 0Altmetric
Review
Clinical implications, benefits and pitfalls of using and reversing non-vitamin K antagonist oral anticoagulants
Alexandra Sophie Moss, Gerasimos Dimitropoulous & Gregory Y. H. Lip
Pages: 833-845
Published online: 31 Jul 2017
AbstractforClinical implications, benefits and pitfalls of using and reversing non-vitamin K antagonist oral anticoagulants | Full Text | References | PDF (909.6 KB)
  • 208 Views
  • 1 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Defining treatment success in chronic lymphocytic leukemia: exploring surrogate markers, comorbidities, and patient-centered endpoints
Stefano Molica
Report | Published online: 13 Jun 2024
Open Access
The evolving management algorithm for the patient with newly diagnosed cold agglutinin disease
Wilma Barcellini et al.
Review Article | Published online: 13 Jun 2024
Open Access
Clinical presentation and management of atypical hemolytic uremic syndrome in Latin America: a narrative review of the literature
R.A. Sepúlveda Palamara et al.
Review Article | Published online: 12 Jun 2024
Open Access
Outcome measures in hemophilia: current and future perspectives
Silvia Benemei et al.
Review Article | Published online: 11 Jun 2024
Open Access
View all latest articles